Clopidogrel (Clopicard 75mg) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Clopicard 75mg) is prescribed ...

Current evidence seems to indicate that due to individual variability in response to clopidogrel, as many as 30% of patients on maintenance clopidogrel (75 mg/day) may show elevated platelet ...

NEW ORLEANS, LA—The debate over the use of pharmacogenomic- or pharmacodynamic-tailored antiplatelet therapy continues to be a subject of interest at ACC.11, the American College of Cardiology’s 60 th ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

New results suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention with drug-eluting stents achieves greater platelet inhibition than conventional dual ...

Expert Rev Clin Pharmacol. 2012;5(3):319-336. Finally, a recent study suggested that although prasugrel significantly reduces thrombotic events in patients with ACS undergoing PCI because of its ...

Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events. We randomly assigned 15,603 patients ...

Gastrointestinal complications are an important problem of antithrombotic therapy. Proton-pump inhibitors (PPIs) are believed to decrease the risk of such complications, though no randomized trial has ...